H. Steigerwald

444 total citations
19 papers, 277 citations indexed

About

H. Steigerwald is a scholar working on Endocrinology, Diabetes and Metabolism, Dermatology and Genetics. According to data from OpenAlex, H. Steigerwald has authored 19 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Dermatology and 3 papers in Genetics. Recurrent topics in H. Steigerwald's work include Diabetes Management and Research (4 papers), Food Allergy and Anaphylaxis Research (3 papers) and Diabetes and associated disorders (3 papers). H. Steigerwald is often cited by papers focused on Diabetes Management and Research (4 papers), Food Allergy and Anaphylaxis Research (3 papers) and Diabetes and associated disorders (3 papers). H. Steigerwald collaborates with scholars based in Germany, Japan and Spain. H. Steigerwald's co-authors include Stephan Scheurer, Stefan Vieths, Stefan Schülke, Masako Toda, Κ. Schöffling, W. Spielmann, E. F. Pfeiffer, S. F. Grebe, Gerhard Treser and M. Otto and has published in prestigious journals such as Scientific Reports, Carbohydrate Polymers and Allergy.

In The Last Decade

H. Steigerwald

17 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Steigerwald Germany 9 73 68 68 65 48 19 277
Francesca Maialetti Italy 11 72 1.0× 55 0.8× 107 1.6× 108 1.7× 20 0.4× 14 429
K Vasudevan India 9 120 1.6× 31 0.5× 66 1.0× 24 0.4× 58 1.2× 16 290
M.M.G. Koning Netherlands 7 168 2.3× 63 0.9× 123 1.8× 112 1.7× 36 0.8× 8 480
Rosa Montella Italy 9 84 1.2× 109 1.6× 84 1.2× 89 1.4× 19 0.4× 11 347
M-P Vasson France 7 92 1.3× 67 1.0× 28 0.4× 50 0.8× 53 1.1× 8 423
Ciriaco Maraschiello Spain 8 74 1.0× 65 1.0× 38 0.6× 54 0.8× 22 0.5× 11 389
Magda Bădescu Romania 10 77 1.1× 57 0.8× 52 0.8× 32 0.5× 77 1.6× 36 315
J Dupont United States 9 65 0.9× 148 2.2× 60 0.9× 19 0.3× 35 0.7× 22 326
P. Kamtchouing Cameroon 12 85 1.2× 29 0.4× 111 1.6× 35 0.5× 120 2.5× 40 457
B Tolomelli Italy 11 92 1.3× 113 1.7× 26 0.4× 30 0.5× 16 0.3× 28 456

Countries citing papers authored by H. Steigerwald

Since Specialization
Citations

This map shows the geographic impact of H. Steigerwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Steigerwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Steigerwald more than expected).

Fields of papers citing papers by H. Steigerwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Steigerwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Steigerwald. The network helps show where H. Steigerwald may publish in the future.

Co-authorship network of co-authors of H. Steigerwald

This figure shows the co-authorship network connecting the top 25 collaborators of H. Steigerwald. A scholar is included among the top collaborators of H. Steigerwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Steigerwald. H. Steigerwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Rojo, David, Alma Villaseñor, Jahidul Islam, et al.. (2024). The impact of high‐IgE levels on metabolome and microbiome in experimental allergic enteritis. Allergy. 79(12). 3430–3447. 1 indexed citations
2.
Steigerwald, H., Melanie Albrecht, Melanie Huch, et al.. (2024). Effects of pectin methyl-esterification on intestinal microbiota and its immunomodulatory properties in naive mice. Carbohydrate Polymers. 334. 122007–122007. 17 indexed citations
3.
Steigerwald, H., Melanie Albrecht, Maren Krause, et al.. (2024). Dietary fiber pectin alters the gut microbiota and diminishes the inflammatory immune responses in an experimental peach allergy mouse model. Scientific Reports. 14(1). 30503–30503. 1 indexed citations
4.
Steigerwald, H., Maren Krause, Irene González-Menéndez, et al.. (2023). Peach extract induces systemic and local immune responses in an experimental food allergy model. Scientific Reports. 13(1). 5 indexed citations
5.
Steigerwald, H., et al.. (2022). Eosinophil‐derived IL ‐4 is necessary to establish the inflammatory structure in innate inflammation. EMBO Molecular Medicine. 15(2). e16796–e16796. 12 indexed citations
6.
Steigerwald, H., Melanie Albrecht, Andrea Wangorsch, et al.. (2021). Does the Food Ingredient Pectin Provide a Risk for Patients Allergic to Non-Specific Lipid-Transfer Proteins?. Foods. 11(1). 13–13. 6 indexed citations
7.
Steigerwald, H., et al.. (2021). The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota. Current Allergy and Asthma Reports. 21(10). 43–43. 133 indexed citations
8.
Steigerwald, H.. (1961). Insulinantikörper. Annals of Hematology. 7(2). 65–68.
9.
Steigerwald, H., et al.. (1960). Neuere Untersuchungen �ber die Antigenwirkung des Insulins. Journal of Molecular Medicine. 38(19). 973–980. 12 indexed citations
10.
Pfeiffer, E. F., et al.. (1957). Die Bedeutung der einmaligen Tablettenbelastung für die Indikationsstellung der oralen Diabetestherapie. DMW - Deutsche Medizinische Wochenschrift. 82(36). 1544–1551. 9 indexed citations
11.
Schöffling, Κ., et al.. (1957). Erfahrungen bei der ambulanten Einstellung und Dauerbehandlung von 758 Zuckerkranken mit D 860. DMW - Deutsche Medizinische Wochenschrift. 82(36). 1515–1518. 1 indexed citations
12.
Steigerwald, H., et al.. (1957). Klinische Kontrolluntersuchungen nach Dauerbehandlung mit D 860. DMW - Deutsche Medizinische Wochenschrift. 82(36). 1525–1526. 1 indexed citations
13.
Schöffling, Κ., et al.. (1957). Die Nebenwirkungen der langfristigen D 860-Behandlung. DMW - Deutsche Medizinische Wochenschrift. 82(36). 1537–1539. 2 indexed citations
14.
Steigerwald, H., et al.. (1957). Das Verhalten des Intermediärstoffwechsels unter Belastungen mit Insulin und D 860 bei Stoffwechselgesunden und Diabetikern. DMW - Deutsche Medizinische Wochenschrift. 82(36). 1554–1556. 2 indexed citations
15.
Schöffling, Κ., et al.. (1957). Das Problem des Sekundärversagens der oralen Diabetesbehandlung. DMW - Deutsche Medizinische Wochenschrift. 82(36). 1528–1531. 12 indexed citations
16.
Creutzfeldt, W., Helmut Maske, William A. Meier, et al.. (1956). Über die orale Behandlung des Diabetes mellitus mit N-[4-Methyl-benzolsulfonyl]-N'-butyl-harnstoff (D 860) Klinische und experimentelle Untersuchungen.. DMW - Deutsche Medizinische Wochenschrift. 81(21). 823–846. 40 indexed citations
17.
Steigerwald, H. & W. Spielmann. (1956). Nachweis von Insulinantik�rpern bei Diabetikern mit Insulinresistenz im H�magglutinationstest und Coombstest. Journal of Molecular Medicine. 34(3-4). 80–84. 9 indexed citations
18.
Steigerwald, H. & Frederik Görlitz. (1956). [A contribution on the question of renal diabetes].. PubMed. 609–14. 1 indexed citations
19.
Pfeiffer, E. F., Κ. Schöffling, W. Sandritter, et al.. (1954). Studien zur „Übertragung“ der Masugi-Nephritis der Ratte: Die „Übertragung“ durch kurzdauernde Parabiose. Research in Experimental Medicine. 124(6). 471–480. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026